Joined April 2021
- Tweets 37
- Following 32
- Followers 38
- Likes 24
20 Photos and videos
Our new international study led by researchers at @MacDeptMed @HEI_McMaster @UofT_DoM identifies the most important risk factors for food allergy development, broadening our understanding of preventing food allergies.
healthsci.mcmaster.ca/what-d…
1
47
Just published review of 2.8 million participants across 190 studies identifying the risk factors associated with the development of food allergies, published in @JAMAPediatrics.
Read here: jamanetwork.com/journals/jam…
Babies given peanuts, fish, eggs early less likely to become allergic, study affirms ctvnews.ca/health/article/ba…
1
13
Evidence in Allergy retweeted
15 Jul 2025
An international study led by researchers with @MacDeptMed have identified the most effective and safest treatments for chronic hives. @dkchu
ow.ly/zBQ950WpUgA
1
1
415
Evidence in Allergy retweeted
5 Nov 2024
Asthma outcomes improve with inhaled corticosteroids plus formoterol, SABA, finds study.
Derek Chu (@dkchu), assistant professor @MacDeptMed, spoke with @GoHealio about the findings of the meta-analysis.
ow.ly/F4YP50U0yYO
1
3
238
Evidence in Allergy retweeted
28 Oct 2024
Combining inhaled corticosteroids (ICS) with short-acting beta-agonists (SABA) and combining ICS with formoterol were each associated with lower risks of severe asthma exacerbations, compared to SABA alone. #ACAAI24 ja.ma/3Ysodm2
27
50
10,897
26 Jun 2024
Do you use topical steroids to manage urticaria? See the evidence in our latest systematic review and meta-analysis, published in @AnnalsAllergy
annallergy.org/article/S1081…
264
13 Jun 2024
Did you know that Evidence in Allergy is Canada's first @worldallergy Center of Excellence?
Our work advances our understanding in allergy, asthma, and clinical immunology
6
4
375
18 Oct 2023
What are the comparative benefits and harms of all the topical and systemic treatments for atopic dermatitis? See @dkchu's recent interview with @GoHealio to learn all the details.
healio.com/news/allergy-asth…
72
Evidence in Allergy retweeted
14 Sep 2023
TODAY IS #WorldAtopicEczemaDay! #AtopicEczema is more than itchy skin, it is a systemic, multidimensional disease that affects the minds & bodies of people around the world - especially youth. globalskin.org/WAED2023
#GlobalSkin #ShareTheBurden #IfYouOnlyKnew
14
30
2,241
Evidence in Allergy retweeted
11 Sep 2023
Findings from a recent review on topical therapy options for patients with atopic dermatitis (AD) have important and immediate implications for achieving optimal AD outcomes, says Derek Chu (@dkchu), assistant professor @MacDeptMed
ow.ly/Sl8C50PKfrT
ALT Person applying lotion to red skin
1
1
502
9 Sep 2023
Thank you to everyone for sharing their comments and feedback on our draft 2023 #AtopicDermatitis Practice Parameter Update. Read the final guideline soon in @AnnalsAllergy
The Joint Task Force on Practice Parameters is sponsored by the @AAAAI_org and @ACAAI
1
107
6 Sep 2023
🚨 Topical treatments are the mainstay for managing #AtopicDermatitis, but with so many options available, how do we choose the best one? Read the new #SystematicReview and network meta-analysis, now published in @jacionline
📄jacionline.org/article/S0091…
ALT Blue text on white background that reads: "What's the best topical treatment option for atopic dermatitis? We analyzed 68 treatments across 43,123 participants in 219 RCTs to find out. Now published in JACI." A cartoon image of assorted tubes and bottles of creams and ointments in a box is on the left.
1
1
939
6 Sep 2023
📢NOW PUBLISHED📢 Discover the most effective and safest systemic treatments for #AtopicDermatitis. Read the latest #SystematicReview and network meta-analysis, now available in @jacionline
📃jacionline.org/article/S0091…
ALT White text on blue background that reads: "What's the best systemic treatment option for atopic dermatitis? We analyzed 75 treatments across 28,686 participants in 149 RCTs to find out. Now published in JACI." A cartoon image of assorted pills and syringes in a box is on the right.
1
4
4
3,064
6 Sep 2023
❗RESULTS❗@alexandro_chu and team compared patient-important outcomes among 75 treatments across 28,686 participants in 149 RCTs. These findings inform optimal #eczema management among patients, caregivers, and clinicians
3
182
Evidence in Allergy retweeted
5 Sep 2023
Let’s step back in time to discover the major milestones in #eczema’s history and, perhaps, catch a glimpse of the future.
Learn more about eczema's origin story: nationaleczema.org/blog/the-…
#GetEczemaWise #atopicdermatitis #dermtwitter
2
311
5 Sep 2023
We're studying new treatment options for people with tree nut #allergies. Have a tree nut allergy and want to learn more? Contact us: evidenceinallergy.com/contac…
ALT The Evidence in Allergy and TRADE logos at the top. The text reads: "Have a tree nut allergy and interested in new treatments? Contact us to learn more and get involved evidenceinallergy.com/contact ". An image of tree nuts on the right.
1
1
312
1 Sep 2023
#ICYMI Moderate-certainty evidence shows that topical calcineurin inhibitors do not increase cancer risk in patients with #eczema. Our findings support the safe use of tacrolimus and pimecrolimus. @LancetChildAdol thelancet.com/journals/lanch…
ALT Graphic that writes "In patients with atopic dermatitis, typical usage of tacrolimus and pimecrolimus do not increase the risk of cancer" with "GRADE moderate certainty" evidence. An image of the first page of the associated journal article is displayed.
1
1
822
Evidence in Allergy retweeted
28 Aug 2023
#DYK that there are 7 different types of #eczema? Treatment options may vary depending on what type you have and it is important to understand the differences. Take a journey with us to guide you through the 7 types of eczema: allergyasthmanetwork.org/wha…
1
5
7
745
24 Jul 2023
We are partnering with @AAAAI_org & @ACAAI to develop an evidence-based, patient-centered guideline on severe asthma.
We are seeking patients & caregivers with lived experience to join our guideline group. If interested, please complete this interest form
forms.gle/6nrPeKVsGs9QQM4d9
112